Capsaicin Dermal Patch

DRUG8 trials

Sponsors

NeurogesX

Conditions

Diabetes MellitusDiabetic NeuropathiesHIV InfectionsHerpes ZosterNeuralgiaPainPeripheral Nervous System DiseasesPolyneuropathies

Phase 2

Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy

NeurogesXHIV Infections

Updated: 2007-09-14

NGX-4010 for the Treatment of Postherpetic Neuralgia

CompletedNCT00061776

NeurogesXHerpes Zoster, Neuralgia, Pain +2

Target: 300Updated: 2008-03-06

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

CompletedNCT00082316

NeurogesXDiabetes Mellitus, Diabetic Neuropathies, Herpes Zoster +5

Updated: 2008-01-11

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

TerminatedNCT00089557

NeurogesXDiabetes Mellitus, Diabetic Neuropathies, Herpes Zoster +5

Updated: 2005-06-24

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)

CompletedNCT00233155

NeurogesXHerpes Zoster, HIV Infections, Neuralgia +2

Start: 2005-08-31End: 2006-12-31Target: 100Updated: 2008-03-06

Phase 3

Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy

CompletedNCT00064623

NeurogesXHIV Infections, Pain, Peripheral Nervous System Diseases

Start: 2003-08-31End: 2005-11-30Target: 300Updated: 2008-03-06

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

CompletedNCT00068081

NeurogesXHerpes Zoster, Neuralgia, Pain +1

Target: 150Updated: 2008-03-06

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

TerminatedNCT00085761

NeurogesXHIV Infections, Pain, Peripheral Nervous System Diseases

Updated: 2008-03-06

Related Papers

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.

2013-01-2840 citations

Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.

2010-10-1137 citations